Cerus Corp (CERS) SEC filings

CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3022% below fair value

$1.94−0.18 (-8.49%)

Close on Nov 12, 2026Market cap $390.96MP/E –Yield –

SEC filings

40 of Cerus's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 2, 2026	SEC EDGAR
Current report	8-K	Nov 2, 2026	Nov 2, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Jul 30, 2026	SEC EDGAR
Current report	8-K	Jul 30, 2026	Jul 30, 2026	SEC EDGAR
Current report	8-K	Jul 6, 2026	Jul 10, 2026	SEC EDGAR
Current report	8-K	Jun 5, 2026	Jun 8, 2026	SEC EDGAR
Current report	8-K	Jun 2, 2026	Jun 3, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	Apr 30, 2026	SEC EDGAR
Current report	8-K	Apr 30, 2026	Apr 30, 2026	SEC EDGAR
Proxy statement	DEF 14A	Apr 22, 2026	Apr 22, 2026	SEC EDGAR
Current report	8-K	Apr 17, 2026	Apr 21, 2026	SEC EDGAR
Current report	8-K	Mar 11, 2026	Mar 16, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 2, 2026	SEC EDGAR
Current report	8-K	Mar 2, 2026	Mar 2, 2026	SEC EDGAR
Current report	8-K	Jan 19, 2026	Jan 23, 2026	SEC EDGAR
Current report	8-K	Jan 11, 2026	Jan 12, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Nov 6, 2025	Nov 6, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 5, 2025	SEC EDGAR
Current report	8-K	Aug 5, 2025	Aug 5, 2025	SEC EDGAR
Current report	8-K	Jun 16, 2025	Jun 23, 2025	SEC EDGAR
Current report	8-K	Jun 3, 2025	Jun 9, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 1, 2025	SEC EDGAR
Current report	8-K	May 1, 2025	May 1, 2025	SEC EDGAR
Proxy statement	DEF 14A	Apr 23, 2025	Apr 23, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Feb 26, 2025	SEC EDGAR
Current report	8-K	Feb 20, 2025	Feb 20, 2025	SEC EDGAR
Current report	8-K	Feb 2, 2025	Feb 6, 2025	SEC EDGAR
Current report	8-K	Jan 13, 2025	Jan 13, 2025	SEC EDGAR
Current report	8-K	Dec 9, 2024	Dec 9, 2024	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Oct 31, 2024	SEC EDGAR
Current report	8-K	Oct 30, 2024	Oct 30, 2024	SEC EDGAR
Current report	8-K	Oct 16, 2024	Oct 16, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 1, 2024	SEC EDGAR
Current report	8-K	Aug 1, 2024	Aug 1, 2024	SEC EDGAR
Current report	8-K	Jul 1, 2024	Jul 2, 2024	SEC EDGAR
Current report	8-K	Jun 5, 2024	Jun 11, 2024	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2024	May 2, 2024	SEC EDGAR
Current report	8-K	May 2, 2024	May 2, 2024	SEC EDGAR
Proxy statement	DEF 14A	Apr 25, 2024	Apr 26, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Cerus's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CERS.

Compare: CERS vs MDXG · CERS vs LMAT · CERS vs PRCT · CERS vs ANGO · CERS vs SIBN

Operating margin-1.0% · median -8.3%

Net margin-2.9% · median -6.9%

Company	Revenue	Growth
PRCT	$352.30M	+17.5%
ANGO	$325.38M	+8.2%
MDXG	$303.73M	-22.8%
LMAT	$269.36M	+11.8%
CERS	$254.23M	–
SIBN	$213.60M	+15.3%

Company

Next earnings (est.): Mar 1, 2027, during market hours
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 275
Held by institutions: 74.8%
Auditor: Ernst & Young LLP
SEC CIK: 1020214

Advertisement
300 × 250

See a number that looks wrong?